Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 2
2008 2
2009 1
2010 2
2011 1
2012 2
2013 1
2014 3
2015 2
2016 1
2017 1
2018 1
2019 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
Adjuvants in vaccines and for immunisation: current trends.
Chiarella P, Massi E, De Robertis M, Signori E, Fazio VM. Chiarella P, et al. Among authors: massi e. Expert Opin Biol Ther. 2007 Oct;7(10):1551-62. doi: 10.1517/14712598.7.10.1551. Expert Opin Biol Ther. 2007. PMID: 17916047 Review.
Recent advances in epitope design for immunotherapy of cancer.
Chiarella P, Massi E, De Robertis M, Fazio VM, Signori E. Chiarella P, et al. Among authors: massi e. Recent Pat Anticancer Drug Discov. 2009 Nov;4(3):227-40. doi: 10.2174/157489209789206922. Recent Pat Anticancer Drug Discov. 2009. PMID: 19522699 Review.
DNA vaccination strategies for anti-tumour effective gene therapy protocols.
Signori E, Iurescia S, Massi E, Fioretti D, Chiarella P, De Robertis M, Rinaldi M, Tonon G, Fazio VM. Signori E, et al. Among authors: massi e. Cancer Immunol Immunother. 2010 Oct;59(10):1583-91. doi: 10.1007/s00262-010-0853-x. Cancer Immunol Immunother. 2010. PMID: 20390416 Review.
Recurrent Mutations in Cyclin D3 Confer Clinical Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia.
Smith CC, Viny AD, Massi E, Kandoth C, Socci ND, Rapaport F, Najm M, Medina-Martinez JS, Papaemmanuil E, Tarver TC, Hsu HH, Le MH, West B, Bollag G, Taylor BS, Levine RL, Shah NP. Smith CC, et al. Among authors: massi e. Clin Cancer Res. 2021 Jul 15;27(14):4003-4011. doi: 10.1158/1078-0432.CCR-20-3458. Epub 2021 Jun 8. Clin Cancer Res. 2021. PMID: 34103301 Free PMC article.
EphB2 stem-related and EphA2 progression-related miRNA-based networks in progressive stages of CRC evolution: clinical significance and potential miRNA drivers.
De Robertis M, Mazza T, Fusilli C, Loiacono L, Poeta ML, Sanchez M, Massi E, Lamorte G, Diodoro MG, Pescarmona E, Signori E, Pesole G, Vescovi AL, Garcia-Foncillas J, Fazio VM. De Robertis M, et al. Among authors: massi e. Mol Cancer. 2018 Nov 30;17(1):169. doi: 10.1186/s12943-018-0912-z. Mol Cancer. 2018. PMID: 30501625 Free PMC article.
20 results